HALOHalozymeHealth Care
$110.42EarningsNov 2, 2026
1D—1W—1M—3M—1Y—
Market cap$13.4BCompany infoRevenue$1.7B52-wk range$62 – $115IndustryBiotechnologyWebsitehalozyme.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +50.7% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E33.0×2841
12
39
P / S8.0×1319
5
13
P / FCF16.6×5664
12
34
EV / EBITDA21.4×2336
9
29
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin78.2%9082
76%
83%
Operating margin56.8%9899
35%
64%
Net margin24.9%8588
23%
92%
ROE165.6%99100
92%
219%
ROIC29.2%9292
13%
30%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity14.9511
3.0
43.9
Net debt / EBITDA2.7×3330
Current ratio2.718069
Interest coverage46.5×8478
Per shareTTM, with year-over-year change
Revenue / share$13.73▲ +41%
EPS (diluted)$3.35▼ −23%
FCF / share$6.65▲ +49%
Est. EPS growth (fwd)—